Bandaram Pharma Packtech Limited (BOM:524602)
India
· Delayed Price · Currency is INR 40.86
+0.04 (0.10%)
At close: Jul 4, 2025
Bandaram Pharma Packtech Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Operating Revenue | 369.64 | 340.79 | 187.32 | - | - | Upgrade
|
Other Revenue | 0 | 0 | - | - | - | Upgrade
|
| 369.64 | 340.79 | 187.32 | - | - | Upgrade
| |
Revenue Growth (YoY) | 8.46% | 81.93% | - | - | - | Upgrade
|
Cost of Revenue | 296.5 | 275.54 | 160.48 | - | - | Upgrade
|
Gross Profit | 73.14 | 65.25 | 26.84 | - | - | Upgrade
|
Selling, General & Admin | 29.57 | 30.43 | 7.96 | - | - | Upgrade
|
Other Operating Expenses | 15.35 | 6.66 | 5.51 | 0.1 | 0.13 | Upgrade
|
Operating Expenses | 54.79 | 44.38 | 19.32 | 0.1 | 0.32 | Upgrade
|
Operating Income | 18.35 | 20.88 | 7.52 | -0.1 | -0.32 | Upgrade
|
Interest Expense | -6.13 | -6.14 | -3.45 | -0 | - | Upgrade
|
Interest & Investment Income | - | 0.02 | 0.03 | - | - | Upgrade
|
Currency Exchange Gain (Loss) | - | - | 0.03 | - | - | Upgrade
|
Other Non Operating Income (Expenses) | 0.94 | -2.89 | -0.87 | - | - | Upgrade
|
EBT Excluding Unusual Items | 13.16 | 11.87 | 3.26 | -0.1 | -0.32 | Upgrade
|
Pretax Income | 13.16 | 11.87 | 3.26 | -0.1 | -0.32 | Upgrade
|
Income Tax Expense | 3.22 | 2.39 | 0.68 | - | - | Upgrade
|
Net Income | 9.94 | 9.48 | 2.58 | -0.1 | -0.32 | Upgrade
|
Net Income to Common | 9.94 | 9.48 | 2.58 | -0.1 | -0.32 | Upgrade
|
Net Income Growth | 4.86% | 268.04% | - | - | - | Upgrade
|
Shares Outstanding (Basic) | 12 | 12 | 3 | 3 | 2 | Upgrade
|
Shares Outstanding (Diluted) | 12 | 12 | 3 | 3 | 2 | Upgrade
|
Shares Change (YoY) | -0.22% | 300.00% | - | 31.75% | 900.15% | Upgrade
|
EPS (Basic) | 0.83 | 0.79 | 0.86 | -0.03 | -0.14 | Upgrade
|
EPS (Diluted) | 0.83 | 0.79 | 0.86 | -0.03 | -0.14 | Upgrade
|
EPS Growth | 5.10% | -7.99% | - | - | - | Upgrade
|
Free Cash Flow | -50.12 | -43.09 | -38.94 | 29.15 | - | Upgrade
|
Free Cash Flow Per Share | -4.19 | -3.59 | -12.98 | 9.72 | - | Upgrade
|
Dividend Per Share | 0.100 | 0.100 | 0.100 | - | - | Upgrade
|
Gross Margin | 19.79% | 19.15% | 14.33% | - | - | Upgrade
|
Operating Margin | 4.96% | 6.13% | 4.01% | - | - | Upgrade
|
Profit Margin | 2.69% | 2.78% | 1.38% | - | - | Upgrade
|
Free Cash Flow Margin | -13.56% | -12.64% | -20.79% | - | - | Upgrade
|
EBITDA | 24.48 | 28.02 | 13.32 | 0.08 | -0.13 | Upgrade
|
EBITDA Margin | 6.62% | 8.22% | 7.11% | - | - | Upgrade
|
D&A For EBITDA | 6.13 | 7.14 | 5.8 | 0.18 | 0.18 | Upgrade
|
EBIT | 18.35 | 20.88 | 7.52 | -0.1 | -0.32 | Upgrade
|
EBIT Margin | 4.96% | 6.13% | 4.01% | - | - | Upgrade
|
Effective Tax Rate | 24.48% | 20.13% | 20.91% | - | - | Upgrade
|
Revenue as Reported | 370.58 | 341.12 | 189.22 | - | - | Upgrade
|
Advertising Expenses | - | 0.15 | 0.37 | - | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.